143 related articles for article (PubMed ID: 9628743)
1. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.
Patrick SM; Turchi JJ
Biochemistry; 1998 Jun; 37(24):8808-15. PubMed ID: 9628743
[TBL] [Abstract][Full Text] [Related]
2. Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA.
Patrick SM; Turchi JJ
J Biol Chem; 1999 May; 274(21):14972-8. PubMed ID: 10329699
[TBL] [Abstract][Full Text] [Related]
3. Recognition of cisplatin-DNA interstrand cross-links by replication protein A.
Patrick SM; Tillison K; Horn JM
Biochemistry; 2008 Sep; 47(38):10188-96. PubMed ID: 18729380
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein.
Turchi JJ; Li M; Henkels KM
Biochemistry; 1996 Mar; 35(9):2992-3000. PubMed ID: 8608137
[TBL] [Abstract][Full Text] [Related]
5. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
6. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
[TBL] [Abstract][Full Text] [Related]
7. Stable binding of human XPC complex to irradiated DNA confers strong discrimination for damaged sites.
Batty D; Rapic'-Otrin V; Levine AS; Wood RD
J Mol Biol; 2000 Jul; 300(2):275-90. PubMed ID: 10873465
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA.
Turchi JJ; Patrick SM; Henkels KM
Biochemistry; 1997 Jun; 36(24):7586-93. PubMed ID: 9200710
[TBL] [Abstract][Full Text] [Related]
9. Overexpression and purification of human XPA using a baculovirus expression system.
Hermanson IL; Turchi JJ
Protein Expr Purif; 2000 Jun; 19(1):1-11. PubMed ID: 10833384
[TBL] [Abstract][Full Text] [Related]
10. Electrospray ionization-mass spectrometry study of the interaction of cisplatin-adducted oligonucleotides with human XPA minimal binding domain protein.
Xu N; Pasa-Tolić L; Smith RD; Ni S; Thrall BD
Anal Biochem; 1999 Jul; 272(1):26-33. PubMed ID: 10405289
[TBL] [Abstract][Full Text] [Related]
11. RPA repair recognition of DNA containing pyrimidines bearing bulky adducts.
Petruseva IO; Tikhanovich IS; Chelobanov BP; Lavrik OI
J Mol Recognit; 2008; 21(3):154-62. PubMed ID: 18438969
[TBL] [Abstract][Full Text] [Related]
12. Interplay between human high mobility group protein 1 and replication protein A on psoralen-cross-linked DNA.
Reddy MC; Christensen J; Vasquez KM
Biochemistry; 2005 Mar; 44(11):4188-95. PubMed ID: 15766246
[TBL] [Abstract][Full Text] [Related]
13. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.
McA'Nulty MM; Whitehead JP; Lippard SJ
Biochemistry; 1996 May; 35(19):6089-99. PubMed ID: 8634251
[TBL] [Abstract][Full Text] [Related]
14. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
[TBL] [Abstract][Full Text] [Related]
15. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.
Pilch DS; Dunham SU; Jamieson ER; Lippard SJ; Breslauer KJ
J Mol Biol; 2000 Feb; 296(3):803-12. PubMed ID: 10677282
[TBL] [Abstract][Full Text] [Related]
16. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
Jung Y; Lippard SJ
Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
[TBL] [Abstract][Full Text] [Related]
17. Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase.
Turchi JJ; Henkels K
J Biol Chem; 1996 Jun; 271(23):13861-7. PubMed ID: 8662830
[TBL] [Abstract][Full Text] [Related]
18. DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.
Dunham SU; Lippard SJ
Biochemistry; 1997 Sep; 36(38):11428-36. PubMed ID: 9298962
[TBL] [Abstract][Full Text] [Related]
19. Interactions of mammalian proteins with cisplatin-damaged DNA.
Turchi JJ; Henkels KM; Hermanson IL; Patrick SM
J Inorg Biochem; 1999 Oct; 77(1-2):83-7. PubMed ID: 10626358
[TBL] [Abstract][Full Text] [Related]
20. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms.
Marples B; Adomat H; Billings PC; Farrell NP; Koch CJ; Skov KA
Anticancer Drug Des; 1994 Oct; 9(5):389-99. PubMed ID: 7945723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
